Close Menu

NEW YORK (GenomeWeb) – Quanterix today said that it has priced a public offering of 2,376,238 shares of its common stock at an offering price of $25.25 per share. 

The Billerica, Massachusetts-based firm expects to bring in around $60 million in gross proceeds, before underwriting discounts and expenses. The company also has granted the underwriters a 30-day option to purchase up to an additional 356,435 shares of common stock at the same offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.